| Subscribe
HOME
NEWS
SPORT
FINANCE
COMMENT
BLOGS
CULTURE
TRAVEL
LIFESTYLE
FASHION
TECH
Dating
Offers
Jobs
UK
World
Politics Space
Obituaries
Education
Earth
Science Evolution
Defence
Health News
Royal Family
Celebrities
Weird News
Science News
Roger Highfield
Dinosaurs
Steve Jones
PROMOTIONS
Loading
TODAY
PAST WEEK
PAST MONTH
1. Whitehall 'threat' to future of science 2. Prof Stephen Hawking too unwell to deliver own 70th birthday speech 3. GlaxoSmithKline fined over trials on the babies of Argentinian poor 4. Neanderthals could have died out because their bodies overheated
Science News News Argentina UK News Pharmaceuticals and Chemicals Pharmaceuticals
IN SCIENCE NEWS
The firm failed to get proper consent from the childrens parents before injecting Synflorix, one of its bestselling vaccines, according to a judge in Buenos Aires. GSK was also criticised for keeping inadequate records of the childrens ages, medical histories and previous jabs. Evidence from Argentina's medical regulator said that, in a few cases, scientists working for GSK relied on permission from under-age parents or illiterate grandparents, The Times reported. GSK and two of the scientists who led the trial have been fined a total of one million pesos (150,000). Jorge Yabkowsky, president of the Argentine Federation of Health Professionals, told The Times: These are people who depend entirely on the state apparatus and who are most often illiterate.
RELATED ARTICLES
COURSES
SERVICES
SCIENCE JOBS
You really can die of a broken heart say scientists 09 Jan 2012 Dark matter 'cosmic web' 09 Jan 2012 'Extinct' Galapagos tortoise still alive 09 Jan 2012 Drinkers should have two 'dry' days a week 08 Jan 2012 How LGC helped solve Stephen Lawrence killing 08 Jan 2012
Loading
They are vulnerable sections of society. They are unable to read any kind of consent form. GSK's recruitment of these people was absolutely unethical. The trial, known as Compas, involved 15,000 Argentine babies and
A year in space
http://www.telegraph.co.uk/science/science-news/9006614/GlaxoSmithKline-fined-over-trials-on-the-babies-of-Argentinian-poor.html
Page 1 / 2
9,000 in Colombia and Panama. The study began five years ago and is continuing. Such work is central to a strategy laid out by Sir Andrew Witty, the chief executive of GSK, who has emphasised vaccines in developing countries as a commercial priority. Sir Andrew, who was knighted in the New Year Honours, wants to diversify away from "white pills in Western markets", The Times reported. GSK paid scientists carrying out the study for each baby signed up. Families were given no financial incentives. A GSK spokesman said: We conduct clinical trials to the same high standards, irrespective of where in the world they are run. This includes the requirement to obtain informed consent from participants. That is a fundamental principle of our behaviour and any deviation is unacceptable. In this case, we proactively alerted the authorities and implemented a corrective action plan. The Argentinian authorities agreed to continue with the study. Looking for planet Earth
Please enable JavaScript to view the comments powered by Disqus. blog comments powered by Disqus
MORE FROM TELEGRAPH.CO.UK TELEGRAPH PROMOTIONS LOOK YOUNGER FOR LONGER MICROSOFT OFFICE 365 AVIOS TRAVEL REWARDS
Learn to eat, exercise and feel better with Matt Roberts New Year fitness plan
View
Iran
Scottish Politics
Sport Football Cricket Fantasy Football Culture Motoring Dating
US Election 2012
Finance Personal Finance Economics Markets Fashion Property Crossword
Financial Crisis
Comment Blogs My Telegraph Letters Technology Gardening
CES 2012
Football
More...
Telegraph Journalists
Today's News
Archive
Style Book
http://www.telegraph.co.uk/science/science-news/9006614/GlaxoSmithKline-fined-over-trials-on-the-babies-of-Argentinian-poor.html
Page 2 / 2